Hypoglycemia is a drop in the level of glucose in the blood, which can cause neurological disorders such as paralysis, double vision or loss of consciousness (blood sugar less than 0.70 g/l). What are the signs of hypoglycemia? Generally, the signs of
DIABNEXT WILL BE IN BERLIN FOR THE ATTD19 CONFERENCE, COME AND SEE OUR DIGITAL DIABETES INNOVATIONS, BOOTH #43
The 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) will take place in Berlin between 20-23 of February. It will bring together a multitude of key players from the diabetes world as well as family providers, scientists, start-ups and many
The pitch competition organized by the Prix Galien distinguishes 8 finalists from more than 50 applications submitted, including DIABNEXT, the hassle-free diabetes monitoring solution. Prix Galien contest 2018 Very honored by this nomination, Laurent NICOLAS states, “We will gradually deploy this technology
DIABNEXT is moving its headquarters to 10 rue Treilhard, in the 8th arrondissement of Paris, France in the Morning Monceau space. This implementation makes it possible to maintain close relations with key hospitals for Diabetes in Europe, and in particular
DIABNEXT ATTENDED THE 11th INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES (ATTD 2018)
Advanced Technologies & Treatments for Diabetes (ATTD) is a unique and innovative conference. The ATTD attracts more than 2,500 participants each year, including leading researchers, clinical practitioners, and industry professionals and companies from around the world to exchange ideas and information on diabetes
“Artificial Intelligence: what impacts on Healthcare?” conference hosting DIABNEXT Executive Chairman Richard Binier HEC 1990 guest speaker
DIABNEXT is launching the first global comprehensive self-management data platform for diabetic patients.
On Monday, October 16th, at the final round of the Diabetes Innovation Challenge in France, the jury of the French Health Insurance
We are thrilled to announce that we are selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit, in Copenhagen, Denmark in November!
DIABNEXT™ the next-generation Diabetes care platform using auto-filled health metrics won on Sept. 19th 2017 the French Grandes Écoles Alumni Association prize in the finals of the French Founder Startup Tour 2017. This innovation challenge, co-organized by French Founders &